Editorial: Is Ribavirin Needed in the Treatment of Post-Transplant Hepatitis C Recurrence?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Hepatitis B Virus Reactivation in Transplant Patients Treated for Hepatitis C Recurrence: Prophylaxis Makes the Difference

Journal of Hepatology
Hepatology
2019English

Decreased Post-Transplant Survival Among Heart Transplant Recipients With Pre-Transplant Hepatitis C Virus Positivity

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2011English

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

American Journal of Gastroenterology
HepatologyGastroenterology
2012English

Viral Eradication and Fibrosis Resolution in Post Liver Transplant Cholestatic Hepatitis C

Liver Transplantation
HepatologyTransplantationSurgery
2018English

SVR Is Associated With a Decreased Risk of Post-Transplant Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C Related Liver Disease

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research
Pharmacology
2005English

Treatment of Chronic Hepatitis C Virus in Allogeneic Bone Marrow Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2005English

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin

Viruses
VirologyInfectious Diseases
2019English

Thyroid Hormonal Disturbances Related to Treatment of Hepatitis C With Interferon-Alpha and Ribavirin

Clinics
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy